Veracyte director proposes $716K share sale
Morgan Stanley Smith Barney LLC is named as broker for the proposed transaction.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Veracyte, Inc. (VCYT) director Karin Eastham reported a proposed sale of 14,850 common shares, with an aggregate market value of $715,770 and an approximate sale date of October 27, 2026. The listed shares comprise 10,000 shares from stock-option exercises and 4,850 shares from restricted stock units. Morgan Stanley Smith Barney LLC is named as broker.
Key Figures
Key Terms
Rule 144 regulatory
Exercise of Stock Options financial
Restricted Stock Units financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.